Top Stories

Pfizer and BioNTech begin the process of seeking full U.S. approval for their Covid vaccine


Vials of the Pfizer-BioNTech Covid-19 vaccine at the Sun City Anthem Community Center vaccination site in Henderson, Nevada, U.S., on Thursday, Feb. 11, 2021.

Roger Kisby | Bloomberg | Getty Images

Pfizer and German drugmaker BioNTech said they’ve started the process of seeking full approval for their Covid-19 vaccine for use in people 16 and older in the U.S., making the companies the first in the nation to file for full regulatory approval.

The Food and Drug Administration granted emergency authorization of their Covid vaccine in late December. Since then, Pfizer has distributed 170 million doses in the U.S., with the goal of delivering 300 million doses by the end of July.

“We are…


China’s trade with the U.S. and Australia grew in April despite tensions

Previous article

Goldman Sachs unveils new cryptocurrency trading team in employee memo

Next article

You may also like

Leave a Reply

Notify of

More in Top Stories